TickerFacts.

Oramed Pharmaceuticals Inc. (ORMP): Share Repurchases

Annual figures by period end, from SEC filings.

$4.74M
Year ended 2025-12-31
2024-12-31: $2.48M2025-12-31: $4.74M$4.74M
2024-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$4.74M+90.9%2026-03-26, From 2025-01-01
2024-12-31$2.48Mn/a2026-03-26, From 2024-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Oramed Pharmaceuticals Inc. (ORMP)2025-12-31$4.74M+90.9%
Siga Technologies Inc (SIGA)2025-12-31$0n/a
Nature's Sunshine Products Inc (NATR)2025-12-31$16.31M+84.1%
Tonix Pharmaceuticals Holding Corp. (TNXP)2025-12-31$13.76Mn/a
Nektar Therapeutics (NKTR)2025-12-31$0-100.0%
Zevra Therapeutics, Inc. (ZVRA)2024-12-31$0-100.0%
Lexicon Pharmaceuticals, Inc. (LXRX)2024-12-31$1.73M+110.0%
Zentalis Pharmaceuticals, Inc. (ZNTL)2025-12-31$9.98Mn/a
Atea Pharmaceuticals, Inc. (AVIR)2025-12-31$25.52Mn/a

Compare ORMP, SIGA, NATR, TNXP side by side · Screen every company in Pharmaceutical Preparations ↗